Almost 90 percent of the pharmaceuticals we buy are generics. Katherine Eban joins host Krys Boyd to talk about how companies frequently ignore safe manufacturing practices in order to maximize the profits of these cheaper drugs – and about how the global scope of the industry makes it difficult to regulate. Her new book is called “Bottle of Lies: The Inside Story of the Generic Drug Boom” (Ecco).
